Efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes and raccoon dogs.

Administration, Oral Animals Antibodies, Viral / immunology Enzyme-Linked Immunosorbent Assay Female Foxes Immunity, Humoral / physiology Male Rabies / immunology Rabies Vaccines / immunology Rabies virus / immunology Raccoon Dogs
Efficacy Genetically engineered vaccine Immunogenicity Oral rabies vaccines Rabies SPBN GASGAGS Wildlife

Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
02 08 2019
Historique:
received: 27 06 2017
revised: 19 09 2017
accepted: 20 09 2017
pubmed: 19 10 2017
medline: 28 7 2020
entrez: 19 10 2017
Statut: ppublish

Résumé

To test the immunogenicity and efficacy of a new oral rabies virus vaccine strain SPBN GASGAS in wildlife target species, one group of foxes and two groups of raccoon dogs were offered a bait containing 1.7 ml of the vaccine (10

Identifiants

DOI: 10.1016/j.vaccine.2017.09.093 PMID: 29042202
pubmed: 29042202
pii: S0264-410X(17)31366-X
doi: 10.1016/j.vaccine.2017.09.093
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Rabies Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4750-4757

Informations de copyright

Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Conrad M Freuling (CM)

Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, 17493 Greifswald-Insel Riems, Germany.

Elisa Eggerbauer (E)

Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, 17493 Greifswald-Insel Riems, Germany.

Stefan Finke (S)

Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, 17493 Greifswald-Insel Riems, Germany.

Christiane Kaiser (C)

IDT Biologika GmbH, 06861 Dessau-Rosslau, Germany.

Christian Kaiser (C)

IDT Biologika GmbH, 06861 Dessau-Rosslau, Germany.

Antje Kretzschmar (A)

IDT Biologika GmbH, 06861 Dessau-Rosslau, Germany.

Tobias Nolden (T)

ViraTherapeutics, 6020 Innsbruck, Austria.

Steffen Ortmann (S)

IDT Biologika GmbH, 06861 Dessau-Rosslau, Germany.

Charlotte Schröder (C)

Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, 17493 Greifswald-Insel Riems, Germany.

Jens P Teifke (JP)

Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, 17493 Greifswald-Insel Riems, Germany.

Peter Schuster (P)

IDT Biologika GmbH, 06861 Dessau-Rosslau, Germany.

Ad Vos (A)

IDT Biologika GmbH, 06861 Dessau-Rosslau, Germany.

Thomas C Mettenleiter (TC)

Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, 17493 Greifswald-Insel Riems, Germany.

Thomas Müller (T)

Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, 17493 Greifswald-Insel Riems, Germany. Electronic address: Thomas.Mueller@fli.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Voies d'administration de substances chimiques et des médicaments › Administration par voie orale › Efficacy of the oral rabies virus vaccine...
questionsmedicales.fr › Eucaryotes › Animaux › Efficacy of the oral rabies virus vaccine...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps antiviraux › Efficacy of the oral rabies virus vaccine...
questionsmedicales.fr › Techniques d'investigation › Techniques de sonde moléculaire › Dosage immunologique › Techniques d'immunoadsorption › Test ELISA › Efficacy of the oral rabies virus vaccine...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Carnivora › Pinnipedia › Canidae › Renards › Efficacy of the oral rabies virus vaccine...
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité acquise › Immunité humorale › Efficacy of the oral rabies virus vaccine...
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Infections à Mononegavirales › Infections à Rhabdoviridae › Rage (maladie) › Efficacy of the oral rabies virus vaccine...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Vaccins antirabiques › Efficacy of the oral rabies virus vaccine...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN de polarité négative › Mononegavirales › Rhabdoviridae › Lyssavirus › Virus de la rage › Efficacy of the oral rabies virus vaccine...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Carnivora › Pinnipedia › Canidae › Chiens viverrins › Efficacy of the oral rabies virus vaccine...